Stay updated on Tiragolumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Tiragolumab in Lung Cancer Clinical Trial page.

Latest updates to the Tiragolumab in Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new site revision note (Revision: v3.4.2) has been added. The previous revision note (Revision: v3.4.1) and the government funding operating-status notice have been removed.SummaryDifference0.2%

- Check22 days agoChange DetectedNew trial locations were added (including Chungbuk National University Hospital in Cheongju and Sendai Kousei Hospital in Miyagi), bringing the total locations to 134, and the recruitment status was updated from Active, not recruiting to Completed. The page also includes a government funding notice and updated study dates (Revision: v3.4.1).SummaryDifference0.5%

- Check29 days agoChange DetectedThe changes add a glossary display toggle and updated metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted) along with the site revision to v3.4.0; These are administrative UI and metadata updates and do not affect the study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedThe update is a minor site revision from v3.3.3 to v3.3.4 with no visible changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check65 days agoChange DetectedLocations list updated with many new sites across the United States, Australia, Europe, and Latin America, and several sites removed. Revision tag updated to v3.3.3.SummaryDifference1%

- Check79 days agoChange DetectedThe study location list expanded to 132 sites worldwide, adding new entries such as Gdańsk and HOCH Health Ostschweiz, and removing several previous sites. Dates were updated to 2025-12-05 and 2025-12, and the primary completion date is now 2026-01-31.SummaryDifference0.7%

Stay in the know with updates to Tiragolumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tiragolumab in Lung Cancer Clinical Trial page.